Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products
Wojciech Jankowski, Yara Park, Joseph R. McGill, et al.
Blood Advances (2019) Vol. 3, Iss. 9, pp. 1429-1440
Open Access | Times Cited: 24

Showing 24 citing articles:

Tolerating Factor VIII: Recent Progress
Sébastien Lacroix‐Desmazes, Jan Voorberg, David Lillicrap, et al.
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 60
HLA-DMB correlates with antitumor immunity and an improved prognosis in endometrial carcinoma tumors
Xiaoyu Xi, Xiaona Zhang, Jianxin Tang, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein
Michael D. Knierman, Megan B. Lannan, Laura J. Spindler, et al.
Cell Reports (2020) Vol. 33, Iss. 9, pp. 108454-108454
Open Access | Times Cited: 41
Assay format diversity in pre-clinical immunogenicity risk assessment: Toward a possible harmonization of antigenicity assays
Axel Ducret, Chloé Ackaert, Juliana Bessa, et al.
mAbs (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 36
2024 White Paper on Recent Issues in Bioanalysis: Evolution of Immunogenicity Assessment beyond ADA/NAb; Regulated Genomic/NGS Assays; Hypersensitivity Reactions; Minimum Noise Reduction; False Positive Range; Modernized Vaccine Approaches; NAb/TAb Correlation (PART 3A – Recommendations on Advanced Strategies for Molecular Assays and Immunogenicity of Gene Therapy, Cell Therapy, Vaccine; Biotherapeutics Immunogenicity Assessment & Clinical Relevance PART 3B – Regulatory …
Omar Tounekti, Sandra Prior, Sarah Wassmer, et al.
Bioanalysis (2025), pp. 1-45
Closed Access
Applying MAPPs Assays to Assess Drug Immunogenicity
Anette Karle
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 33
Advances in knowledge of inhibitor formation in severe haemophilia A
Matthew Cormier, Paul Batty, Julie Tarrant, et al.
British Journal of Haematology (2020) Vol. 189, Iss. 1, pp. 39-53
Open Access | Times Cited: 32
Specificity of the T Cell Response to Protein Biopharmaceuticals
Sylvain Meunier, Marie de Bourayne, Moustafa Hamze, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 18
Preclinical risk assessment strategy to mitigate the T-cell dependent immunogenicity of protein biotherapeutics: State of the art, challenges and future perspectives
Andrea Di Ianni, Luca Barbero, Tiziana Fraone, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 234, pp. 115500-115500
Closed Access | Times Cited: 6
Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell Epitopes
Katharina Hartman, Guido Steiner, Michel Siegel, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1265-1265
Open Access | Times Cited: 6
Comparative glycosylation mapping of plasma-derived and recombinant human factor VIII
Jingyao Qu, Cheng Ma, Xiaoqian Xu, et al.
PLoS ONE (2020) Vol. 15, Iss. 5, pp. e0233576-e0233576
Open Access | Times Cited: 16
Cas9-derived peptides presented by MHC Class II that elicit proliferation of CD4+ T-cells
Vijaya L. Simhadri, Louis Hopkins, Joseph R. McGill, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 14
HLA Variants and Inhibitor Development in Hemophilia A: A Retrospective Case-Controlled Study Using the ATHNdataset
Joseph R. McGill, Vijaya L. Simhadri, Zuben E. Sauna
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 13
Structural, functional, and immunogenicity implications of F9 gene recoding
Upendra Katneni, Aikaterini Alexaki, Ryan Hunt, et al.
Blood Advances (2022) Vol. 6, Iss. 13, pp. 3932-3944
Open Access | Times Cited: 9
A machine learning approach for identifying variables associated with risk of developing neutralizing antidrug antibodies to factor VIII
Atul Rawal, Christopher Kidchob, Jiayi Ou, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16331-e16331
Open Access | Times Cited: 4
FASTMAP—a flexible and scalable immunopeptidomics pipeline for HLA- and antigen-specific T-cell epitope mapping based on artificial antigen-presenting cells
Luisa Weisbrod, Luigi Capriotti, Marco H. Hofmann, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Development of a novel fully functional coagulation factor VIII with reduced immunogenicity utilizing an in silico prediction and deimmunization approach
Karina Winterling, William Martin, Anne S. De Groot, et al.
Journal of Thrombosis and Haemostasis (2021) Vol. 19, Iss. 9, pp. 2161-2170
Open Access | Times Cited: 10
Immunogenicity of Therapeutic Biological Modalities - Lessons from Hemophilia A Therapies
Nhan H. Nguyen, Nicole L. Jarvi, Sathy V. Balu‐Iyer
Journal of Pharmaceutical Sciences (2023) Vol. 112, Iss. 9, pp. 2347-2370
Open Access | Times Cited: 3
In Vitro Immunogenicity Prediction: Bridging between Innate and Adaptive Immunity
Sivan Cohen, Shan Chung
Bioanalysis (2021) Vol. 13, Iss. 13, pp. 1071-1081
Closed Access | Times Cited: 8
Quantitative HLA‐class‐II/factor VIII (FVIII) peptidomic variation in dendritic cells correlates with the immunogenic potential of therapeutic FVIII proteins in hemophilia A
Vincent P. Diego, Bernadette W. Luu, Marco H. Hofmann, et al.
Journal of Thrombosis and Haemostasis (2019) Vol. 18, Iss. 1, pp. 201-216
Open Access | Times Cited: 6
FVIII peptides presented on HLA-DP and identification of an A3 domain peptide binding with high affinity to the commonly expressed HLA-DP4
Mariarosaria Miranda, Bjarke Endel Hansen, Batoul Wehbi, et al.
Haematologica (2024)
Open Access
The MHC Associated Peptide Proteomics assay is a useful tool for the non-clinical assessment of immunogenicity
Wojciech Jankowski, Christopher Kidchob, Campbell Bunce, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Methods to Evaluate the Effects of Synonymous Variants
Brian Lin, Katarzyna I. Jankowska, Douglas Meyer, et al.
Springer eBooks (2022), pp. 133-168
Closed Access | Times Cited: 1
A Scan of Pleiotropic Immune Mediated Disease Genes Identifies Novel Determinants of Baseline FVIII Inhibitor Status in Hemophilia-A
Tom E. Howard, Marcio Almieda, Vincent P. Diego, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top